Image by icanhascheezburger
AquaBounty Technologies applied to the FDA for formal
approval of their transgenic salmon, AquAdvantage Salmon, in 1995. It is now
2013 and they are still waiting to hear the verdict. So what exactly are these
transgenic salmon and why are they not available on the market even after
eighteen years of waiting?
AquAdvantage fish are genetically modified Atlantic
Salmon that grow much faster than their unaltered brethren. Usually, Atlantic
Salmon only grow in the summer, when the warm waters trigger the production of
growth hormones. Scientists at AquaBounty, however, found a way to promote the
production of these hormones no matter what the season. They located a
promoter, a sequence of regulatory DNA, in ocean pout (an electric eel-like
fish that thrives in icy waters) that is turned on in cold temperatures. Once
turned on, the promoter activates what ever gene follows it. By linking
this cold-triggered promoter to the gene for growth hormone in salmon, AquaBounty
created AquAdvantage Salmon-- fish that would grow twice as fast as the naturally occurring Atlantic salmon.
These genetically modified fish bring about both economic and ecological benefits. As Bryan Walsh points out in his article in TIME Magazine, "Frankenfish: Is GM Salmon a Vital Part of Our Future", the U.S. currently gets much of its salmon from abroad because of the lower cost. Shipping in fish from other countries means we are leaving behind a large carbon footprint in the form of fuel guzzling ships. Ronald Stotish, CEO of AquaBounty, believes that AquAdvantage fish would allow the U.S. to significantly reduce this carbon footprint by growing "salmon in land-based systems [at home], raising fresh seafood close to where it's needed".
Cartoon courtesy of Mike Keefe
Though the FDA concluded that these fish are safe to eat and pose no substantial impact on the environment, they have yet to approve them for sale on the market. One hindrance is the fear of the negative effects they may pose on wild salmon populations if they happen to escape. AquaBounty, however, ensures that it will take all necessary precautions to make sure that never happens. In her book, Frankenstein's Cat: Cuddling Up To Biotech's Brave New Beasts, Emily Anthes reveals that AquaBounty will breed their fish in secure facilities, raising them in confined tanks away from their natural environments. As an additional precaution, "the company also plans to produce only sterile female fish-- incapable of passing their genes on even if they did somehow end up on the lam" (Anthes, 24).
Despite these efforts, AquaBounty still has its fair share of critics as some supermarkets claim that they will not stock AquAdvantage salmon even if the FDA approved them. Andrew Pollack discusses this issue in his article for the New York Times titled "Grocery Chains Won't Sell Altered Fish, Groups Say". In this article, Pollack reports the opinions of some of these chains including Aldi, whose spokeswoman states that Aldi's "current definition of sustainable seafood specifies the exclusion of genetically modified organisms". According to Pollack, other critics believe that the fish hasn't been safety-tested enough to be sold commercially and that the public won't want to eat it. When the FDA has stated that these fish "would be as safe to eat as conventional salmon", I have to wonder if these critics' fears are fueled more so by unease towards the world of genetic engineering than by health and environmental concerns.
Movie Poster for the 2004 film Frankenfish via IMDb
Sources:
Anthes, E. (2013). Frankenstein's Cat: Cuddling up to
Biotech's Brave New Beasts. New York: Scientific American/Farrar, Straus
and Giroux.
Pollack, A. (March 20, 2013). "Grocers Won't Sell
Altered Fish, Groups Say". NY Times. Retrieved Oct. 11, 2013 from http://www.nytimes.com/2013/03/20/business/grocery-chains-pledge-not-to-sell-modified-salmon.html?_r=0
Walsh, B. (July 12, 2011). “Frankenfish: Is GM Salmon a
Vital Part of Our Future?”. TIME
Magazine. Retrieved Oct. 11, 2013 from
No comments:
Post a Comment